Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kester

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Burn Care & Rehabilitation|May 1, 1990
Major burns managed without blood or blood productsS Schlagintweit, C F Snelling, E Germann, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|September 1, 1993
Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trialA Hidding, S van der Linden, M Boers, et al.
Molecular Endocrinology (Baltimore, Md.)|March 14, 2008
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10Edith C H Friesema, Jurgen Jansen, Jan-Willem Jachtenberg, et al.
Clinical Orthopaedics and Related Research|January 1, 1994
Wear and corrosion of modular interfaces in total hip replacementsS D Cook, R L Barrack, G C Baffes, et al.
Nucleic Acids Research|May 21, 1998
SCP2: a major protein component of the axial elements of synaptonemal complexes of the ratH H Offenberg, J A Schalk, R L Meuwissen, et al.
The American Journal of Dermatopathology|June 25, 2025
A Stranger in the Slide: A Rare Collision of a Spitz Melanocytoma With a Novel MYH9::LTK Fusion and a Common BRAF Mutated Nevus Mimicking a Melanoma With a Preexistent NevusPuk R Meijs-Hermanns, Juliette M J Spitzer-Naaijkens, Lennart A Kester, et al.
Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profileT W von Geldern, C Hutchins, J A Kester, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2023
Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencingW de Koning, F F Feenstra, F G J Calkoen, et al.
Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 2. Structure-activity studiesT W von Geldern, J A Kester, R Bal, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 8, 2006
In vitro profiling of the endocrine-disrupting potency of brominated flame retardantsTimo Hamers, Jorke H Kamstra, Edwin Sonneveld, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Burn Care & Rehabilitation|May 1, 1990
Major burns managed without blood or blood productsS Schlagintweit, C F Snelling, E Germann, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|September 1, 1993
Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trialA Hidding, S van der Linden, M Boers, et al.
Molecular Endocrinology (Baltimore, Md.)|March 14, 2008
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10Edith C H Friesema, Jurgen Jansen, Jan-Willem Jachtenberg, et al.
Clinical Orthopaedics and Related Research|January 1, 1994
Wear and corrosion of modular interfaces in total hip replacementsS D Cook, R L Barrack, G C Baffes, et al.
Nucleic Acids Research|May 21, 1998
SCP2: a major protein component of the axial elements of synaptonemal complexes of the ratH H Offenberg, J A Schalk, R L Meuwissen, et al.
The American Journal of Dermatopathology|June 25, 2025
A Stranger in the Slide: A Rare Collision of a Spitz Melanocytoma With a Novel MYH9::LTK Fusion and a Common BRAF Mutated Nevus Mimicking a Melanoma With a Preexistent NevusPuk R Meijs-Hermanns, Juliette M J Spitzer-Naaijkens, Lennart A Kester, et al.
Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profileT W von Geldern, C Hutchins, J A Kester, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2023
Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencingW de Koning, F F Feenstra, F G J Calkoen, et al.
Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 2. Structure-activity studiesT W von Geldern, J A Kester, R Bal, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 8, 2006
In vitro profiling of the endocrine-disrupting potency of brominated flame retardantsTimo Hamers, Jorke H Kamstra, Edwin Sonneveld, et al.
Pageof 14